FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1988600076> ?p ?o ?g. }

• W1988600076 endingPage "700" @default.
• W1988600076 startingPage "683" @default.
• W1988600076 abstract "We describe a bovine embryo culture system that supports repeatable high development in the presence of serum or BSA as well as under defined conditions in the absence of those components. In the first experiment, embryo development in SOF with amino acids (SOFaa), sodium citrate (SOFaac) and myo-inositol (SOFaaci) and with BSA or polyvinyl alcohol (PVA) was compared with that in a M199 granulosa cell co-culture (M199 co-culture). Subsequently, development and cell numbers of blastocysts cultured under defined conditions in SOFaaci with PVA (SOFaaci-PVA), or under undefined conditions in SOFaaci with 5% cow serum (SOFaaciCS) or M199 co-culture were compared. The repeatability of culture results in SOFaaci-CS was checked by weekly replicates (n = 30) spread over 11 months. The viability of embryos developed in SOFaaci-PVA was estimated by transfer of morphologically good blastocysts (n = 10) to synchronized recipients. In the second experiment, the effect of omitting CS or BSA from IVM and IVM-IVF on subsequent embryo development in SOFaaci-PVA or in SOFaaci-CS was investigated. Blastocyst development in SOFaa-PVA, SOFaac-PVA, SOFaa-BSA and M199 was 16 ± 3, 23 ± 2ab, 30 ± 8a and 36 ± 7a%, respectively (Pab < 0.05). Additional inclusion of myoinositol resulted in 42 ± 1a% blastocysts in SOFaaci-PVA vs 19 ± 3b% in SOFaac-PVA, 47 ± 7a% in SOFaac-BSA, and 36 ± 7a% in M199 co-culture, respectively (Pab < 0.01). In 30 replicates, the average cleavage and blastocyst rates of oocytes in SOFaaci-CS were 87 ± 4 and 49 ± 5%, respectively. Five normal calves were produced after transfer of 10 blastocysts developed in defined culture medium (i.e., SOFaaci-PVA). Defined IVM or IVM-IVF (i.e., in absence of CS and BSA) reduced cleavage rates (83 ± 3 and 55 ± 3% vs 90 ± 1% in presence of CS; P < 0.01). Subsequent embryo development in SOFaaci-CS was not affected in either of these defined conditions. However, cleavage and blastocyst rates under completely defined IVP conditions were 54 ± 7 and 19 ± 4%, respectively. It was concluded that under defined culture conditions, addition of citrate and myo-inositol improved blastocyst development to rates comparable to those obtained with serum, BSA or co-culture and that the quality of blastocysts was not affected by the absence of serum or BSA. However, serum was essential during IVM/IVF for normal fertilization and subsequent high blastocyst development." @default.
• W1988600076 created "2016-06-24" @default.
• W1988600076 creator A5025622203 @default.
• W1988600076 creator A5045184605 @default.
• W1988600076 creator A5046073832 @default.
• W1988600076 creator A5084276968 @default.
• W1988600076 creator A5087658605 @default.
• W1988600076 date "1999-09-01" @default.
• W1988600076 modified "2023-10-01" @default.
• W1988600076 title "High bovine blastocyst development in a static in vitro production system using sofaa medium supplemented with sodium citrate and myo-inositol with or without serum-proteins" @default.
• W1988600076 cites W1540276158 @default.
• W1988600076 cites W1915615505 @default.
• W1988600076 cites W1967284317 @default.
• W1988600076 cites W1975017246 @default.
• W1988600076 cites W1978521612 @default.
• W1988600076 cites W1978590716 @default.
• W1988600076 cites W1981731239 @default.
• W1988600076 cites W1983140365 @default.
• W1988600076 cites W1984719365 @default.
• W1988600076 cites W1986914389 @default.
• W1988600076 cites W1989369399 @default.
• W1988600076 cites W1998026506 @default.
• W1988600076 cites W2005380259 @default.
• W1988600076 cites W2008803545 @default.
• W1988600076 cites W2011282906 @default.
• W1988600076 cites W2012729430 @default.
• W1988600076 cites W2014171932 @default.
• W1988600076 cites W2014722771 @default.
• W1988600076 cites W2015173641 @default.
• W1988600076 cites W2016535409 @default.
• W1988600076 cites W2018711411 @default.
• W1988600076 cites W2019588392 @default.
• W1988600076 cites W2022691143 @default.
• W1988600076 cites W2023149399 @default.
• W1988600076 cites W2023272679 @default.
• W1988600076 cites W2025273058 @default.
• W1988600076 cites W2026843885 @default.
• W1988600076 cites W2033411568 @default.
• W1988600076 cites W2044412282 @default.
• W1988600076 cites W2062920544 @default.
• W1988600076 cites W2067744211 @default.
• W1988600076 cites W2070269316 @default.
• W1988600076 cites W2070488187 @default.
• W1988600076 cites W2072526865 @default.
• W1988600076 cites W2074098089 @default.
• W1988600076 cites W2079812680 @default.
• W1988600076 cites W2080973680 @default.
• W1988600076 cites W2085360111 @default.
• W1988600076 cites W2086028080 @default.
• W1988600076 cites W2092359697 @default.
• W1988600076 cites W2100335919 @default.
• W1988600076 cites W2115097877 @default.
• W1988600076 cites W2116890038 @default.
• W1988600076 cites W2139789898 @default.
• W1988600076 cites W2146402876 @default.
• W1988600076 cites W2168540359 @default.
• W1988600076 cites W2168899018 @default.
• W1988600076 doi "https://doi.org/10.1016/s0093-691x(99)00162-4" @default.
• W1988600076 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10734366" @default.
• W1988600076 hasPublicationYear "1999" @default.
• W1988600076 type Work @default.
• W1988600076 sameAs 1988600076 @default.
• W1988600076 citedByCount "656" @default.
• W1988600076 countsByYear W19886000762012 @default.
• W1988600076 countsByYear W19886000762013 @default.
• W1988600076 countsByYear W19886000762014 @default.
• W1988600076 countsByYear W19886000762015 @default.
• W1988600076 countsByYear W19886000762016 @default.
• W1988600076 countsByYear W19886000762017 @default.
• W1988600076 countsByYear W19886000762018 @default.
• W1988600076 countsByYear W19886000762019 @default.
• W1988600076 countsByYear W19886000762020 @default.
• W1988600076 countsByYear W19886000762021 @default.
• W1988600076 countsByYear W19886000762022 @default.
• W1988600076 countsByYear W19886000762023 @default.
• W1988600076 crossrefType "journal-article" @default.
• W1988600076 hasAuthorship W1988600076A5025622203 @default.
• W1988600076 hasAuthorship W1988600076A5045184605 @default.
• W1988600076 hasAuthorship W1988600076A5046073832 @default.
• W1988600076 hasAuthorship W1988600076A5084276968 @default.
• W1988600076 hasAuthorship W1988600076A5087658605 @default.
• W1988600076 hasConcept C142724271 @default.
• W1988600076 hasConcept C16685009 @default.
• W1988600076 hasConcept C178790620 @default.
• W1988600076 hasConcept C179933525 @default.
• W1988600076 hasConcept C185592680 @default.
• W1988600076 hasConcept C196843134 @default.
• W1988600076 hasConcept C202751555 @default.
• W1988600076 hasConcept C203014093 @default.
• W1988600076 hasConcept C2778177303 @default.
• W1988600076 hasConcept C2779335785 @default.
• W1988600076 hasConcept C2780742167 @default.
• W1988600076 hasConcept C537181965 @default.
• W1988600076 hasConcept C54355233 @default.
• W1988600076 hasConcept C55493867 @default.
• W1988600076 hasConcept C71924100 @default.
• W1988600076 hasConcept C86803240 @default.
• W1988600076 hasConcept C87073359 @default.

• next